Total Funding
11
31
Total FundingDebt Financing raised
Growth Score
-1 pts
Heat Score
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
1239425
Chesapeake PERL is a biotechnology company that develops and produces proteins such as humanized glycoproteins and therapeutics.
Catherine E. Vorwald: Director, Business Development
About the Company
Chesapeake PERL, Inc., a biotechnology company, develops and produces proteins for biotechnology markets in the United States. It produces humanized glycoproteins and human therapeutics, including kinases, viral antigens, growth factors, and antibodies. The company manufactures proteins in non-glycosylated or contains insect glycan patterns. Its
proteins are used in various applications, including therapeutics, diagnostics, industrial enzymes, agriculture, bioremediation, and biotechnology tools. The company was founded in 2000 and is based in Savage, Maryland.
